Bridgeway Capital Management, LLC Synthetic Biologics, Inc. Transaction History

Bridgeway Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.3 - $4.3 $170,890 - $319,490	-74,300 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$4.6 - $7.2 $161,000 - $252,000	-35,000 Reduced 32.02%	74,300 $45,000
Q2 2020 Aug 14, 2020	BUY	$2.8 - $5.7 $306,040 - $623,010	109,300 New	109,300 $56,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.